AcuityMD, the AI platform for MedTech, announced: “Prescription data now available in AcuityAI” The update merges prescription and procedure data in one workflow for commercial teams. This addition provides AcuityMD sales reps with increased visibility into healthcare professionals (HCPs). AcuityAI helps reps discover HCPs treating patients on relevant prescription therapies. These therapies are comprised of both branded and generic medications.
“One of our biggest opportunities is identifying the physicians who prescribe the most benign prostatic hyperplasia (BPH) medications and demonstrating how our device, the UroLift System, offers an alternative treatment option for patients seeking symptom relief,” said Jim Brezicki, Manager of Sales Operations & Market Intelligence, Teleflex. “With this data, we can target the right physicians, prioritize opportunities, and drive more meaningful conversations.”
The new capability helps MedTech teams connect prescription activity with potential device opportunities. Previously, procedure data provided only part of the information required by commercial teams. For example, an HCP may treat patients with medications linked to a device opportunity. However, that physician may not perform the related procedure yet. Therefore, procedure data alone may not reveal the full opportunity.
“Before AcuityMD, we had to look up prescription data provider by provider, which was incredibly time-consuming,” said Amy Conner, Director of Market Access and Health Economics and Outcomes Research (HEOR), Echosens. “Now we can see every provider, compare prescription volumes alongside FibroScan utilization, and quickly identify practices that are scanning but not treating, or treating without using FibroScan. Having all of that data in one place, with AI to help us analyze it, has completely changed how we identify opportunities.”
“We incorporated prescription data into AcuityAI in response to customers’ frustrations with existing prescription data solutions and the inability to reliably find the HCPs treating device-eligible patients,” said Brian Collins, Chief Product Officer, AcuityMD. “With AcuityAI, reps can simply ask the questions they need answered and use prescription insights alongside procedures and diagnoses to find and prioritize the right HCPs. It brings another important signal into the hands of the people closest to the customer.”
Prescription information can provide another important signal. It can help teams understand which HCPs manage patients who may benefit from specific medical devices. However, prescription insights often remain difficult to access. Data can sit across multiple systems and create additional work for commercial teams. As a result, sales representatives may spend significant time finding relevant information.
AcuityAI AcuityMD combines these data sources in a single workflow. Then they can look at prescribing patterns versus procedures and diagnoses. This approach can help you have more informed conversations with your health care providers.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
